Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
| Cas No. | 1258595-14-0 |
|---|---|
| Purity | ≥99% |
| Formula | C29H32F2N3O7P |
| Formula Wt. | 603.56 |
| IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
| Synonym | LHC165 |
| Appearance | Pale yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Synthesis impurity
Mast cell destabilizer; potential TRP antagonis...
Core structure of melatonin; potential PPARγ a...
HDAC inhibitor, RNA splicing modulator.
SIRT1/2 inhibitor, indirect p53 activator.
Tropane alkaloid found in plants in the Solanac...
Flavone found in Teucrium.
Hydrazine derivative, DNA alkylator; MAO inhibi...
Tetracycline; protein translation inhibitor, MM...
Synthetic antifungal.
Cholesterol ester transfer protein inhibitor.
Triterpene saponin found in species of Panax; 2...
Endogenous peptide hormone involved in feeding ...
Endogenous neuropeptide, involved in energy hom...
Thienopyridine; P2Y12 antagonist.
Tenoxicam impurity
Kawain derivative, lactone found in Piper methy...
Cathepsin inhibitor.
Glycoprotein IIb/IIIa inhibitor.
Non-depolarizing NMJ blocker; AChR antagonist.<...